June 30, 2017
Oxford BioDynamics names new CFO
Oxford BioDynamics, focused on the epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, has appointed new chief financial officer who is expected to join the company by the mid of September 2017.